By HongKong DengYue Medicine
The global pharmaceutical landscape is undergoing a profound transformation, and Chinese innovative drugs are at the forefront of this shift. In 2025, China's out-licensing (License-out) deals for innovative drugs reached a staggering total value of approximately $1,356.55 billion (around 9,483 billion RMB), with 157 transactions and upfront payments totaling $70...
French 
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek